Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita.

Blood
Matt KnudsonFrederick Goldman

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure disorder characterized by abnormal skin pigmentation and nail dystrophy. We have recently described, in 10 members of a large 3-generation family, an autosomal-dominant form of DC (AD DC) that is due to a mutation in the gene-encoding human telomerase RNA (TERC), resulting in telomere shortening. In studying the immunologic consequences of TERC mutations, severe B lymphopenia and decreased immunoglobulin M (IgM) levels were noted. T cells were found to overexpress senescent markers, including CD57 and Fas receptor, and were moderately reduced in cell number. To determine whether these in vivo findings were related to cellular replicative defects, short-term cultures of AD DC lymphocytes were established to measure proliferation, mitoses, and apoptosis. AD DC lymphocytes displayed a markedly reduced proliferative capacity and increased basal apoptotic rate. Finally, telomere shortening was most prominent in third-generation subjects, and there appeared to be a correlation between telomere length and in vivo and in vitro immune findings. In summary, the observed lymphopenia and hypogammaglobulinemia in AD DC is likely a consequence of replicative failure and prematur...Continue Reading

References

Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R C AllsoppC B Harley
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·N P WengR J Hodes
Apr 1, 1996·Clinical and Experimental Immunology·F KernH D Volk
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·N P WengR J Hodes
Jul 17, 1998·The Journal of Clinical Investigation·F D GoldmanN Taylor
Feb 2, 2000·The EMBO Journal·E HerreraM A Blasco
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E HooijbergH Spits
Oct 29, 2000·British Journal of Haematology·I Dokal
Jul 26, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Frederick D GoldmanRobert T Cook
Sep 5, 2002·Nature Reviews. Immunology·Richard J HodesNan-ping Weng
Sep 17, 2002·Biogerontology·Ronan T BreeAfshin Samali
Jan 11, 2003·Science·Davide RuggeroPier Paolo Pandolfi
Jan 23, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Philip J Mason
Apr 12, 2003·Blood·Alexander RothRosalie M Luiten

❮ Previous
Next ❯

Citations

Sep 12, 2012·Nature Reviews. Genetics·Mary Armanios, Elizabeth H Blackburn
Mar 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi FujiiCornelia M Weyand
Jan 23, 2013·Journal of Pediatric Hematology/oncology·Sonia LabarinasMarc Ansari
May 8, 2009·Pediatric Dermatology·Silvia V LourençoMarcello Menta S Nico
May 2, 2009·Annual Review of Genomics and Human Genetics·Mary Armanios
Mar 14, 2009·Blood·Blanche P AlterPhilip S Rosenberg
Jun 8, 2013·Disease Models & Mechanisms·Monique AnchelinMaría L Cayuela
Oct 15, 2013·PloS One·Larisa PereboevaFrederick Goldman
Oct 7, 2005·International Journal of Hematology·Jichun Chen
Oct 16, 2012·Current Pharmaceutical Design·Jennifer P Chou, Rita B Effros
Nov 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Fred GoldmanMonica Bessler
Dec 31, 2015·The New England Journal of Medicine·Jolan E WalterCatherine Hagen
Jun 19, 2009·Current Opinion in Immunology·Yan Liu, Norman E Sharpless
Jan 18, 2008·Mechanisms of Ageing and Development·Nan-ping Weng
Dec 1, 2007·Mechanisms of Ageing and Development·Emanuela M IancuNathalie Rufer
Apr 25, 2007·Molecular Reproduction and Development·Basil AlexanderW Allan King
Dec 12, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·C ReimannW Vanscheidt
May 3, 2008·Cancer Science·Jin Sung JangJae Yong Park
Nov 11, 2010·Clinical and Experimental Immunology·S KhanA Huissoon
Jan 13, 2012·Annals of the New York Academy of Sciences·Stephan BorteLennart Hammarström
Feb 3, 2011·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·S JyonouchiK E Sullivan
Oct 20, 2011·Pediatric Pulmonology·Rushani W SaltzmanKathleen E Sullivan
Apr 12, 2011·British Journal of Haematology·Michael KirwanInderjeet Dokal
Feb 22, 2012·British Journal of Haematology·Sujith Samarasinghe, David K H Webb
Jun 10, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Farzana PashankarFrederick D Goldman
Feb 14, 2013·The Journal of Allergy and Clinical Immunology·Eric J AllenspachTroy R Torgerson
May 13, 2015·American Journal of Hematology·Neelam GiriLigia A Pinto
Jul 24, 2014·Archives of Disease in Childhood·Valentina CopettiAlberto Tommasini
Dec 1, 2009·American Journal of Human Genetics·Mary ArmaniosCarol W Greider
Sep 23, 2014·Blood·Danielle M TownsleyNeal S Young
Jul 2, 2014·PloS One·Arun AsokTania L Roth
Jan 28, 2017·The Journal of Allergy and Clinical Immunology·Geraldine AubertNicholas L Rider
Feb 26, 2016·Clinical and Vaccine Immunology : CVI·Roshini S Abraham, Geraldine Aubert
Sep 5, 2018·The Journal of Clinical Investigation·Christa L WagnerMary Armanios
Dec 20, 2018·American Journal of Respiratory and Critical Care Medicine·Chad A NewtonChristine Kim Garcia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis